Coordinator Michael Schultz News Today : Breaking News, Live Updates & Top Stories | Vimarsana

The first round of the Moderna vaccine was administered to the School of Dental Medicine’s faculty and staff on Jan. 12.

  For COVID-19 Response Coordinator Michael Schultz, the first task was finding a company to take on testing the university. He said Shield Illinois was the first company he hoped would do the job.   “First we were going to go with Shield Illinois with the University of Illinois system and that was our plan,” Schultz said. “We gave them a deadline of when they needed to be FDA approved and they weren’t [approved by the deadline].”   Instead, he went with GENETEWORx, a testing company based out of Virginia. There were four categories that were most important t...

SIUE held a virtual town hall meeting to discuss mandatory re-entry testing and campus procedures for the Spring 2021 semester. A new dashboard will replace the old COVID Dashboard on